Drug distribution in nanostructured lipid particles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 110, Issue , 2017, Pages 19-23

  Saeidpour, Siavash ^a   Lohan, Silke B ^b   Solik, Agnieszka ^a   Paul, Victoria ^b   Bodmeier, Roland ^a   Zoubari, Gaith ^a   Bittl, Robert ^a   Meinke, Martina C ^b   Teutloff, Christian ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Dermal drug delivery; Dexamethasone; Drug delivery system; Electron paramagnetic resonance (EPR) spectroscopy; Lipids; Nanoparticles; Spinlabel

Indexed keywords

DEXAMETHASONE; GELUCIRE; SOLID LIPID NANOPARTICLE; WATER; WITEPSOL; CAPRYOL PROPYLENE GLYCOL MONOCAPRYLATE; COLLOID; DRUG CARRIER; FAT; GELUCIRE 50-13; GLUCOCORTICOID; LIPID; NANOPARTICLE; OIL; POLYMER; PROPANEDIOL DERIVATIVE; SPIN LABEL; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG DISTRIBUTION; DRUG RELEASE; ELECTRON SPIN RESONANCE; MAGNETISM; NANOPHARMACEUTICS; ROOM TEMPERATURE; SURFACE PROPERTY; CHEMISTRY; COLD; COLLOID; DRUG DESIGN; PARTICLE SIZE; SOLUBILITY;

COLD TEMPERATURE; COLLOIDS; DEXAMETHASONE; DRUG CARRIERS; DRUG DESIGN; ELECTRON SPIN RESONANCE SPECTROSCOPY; FATS; GLUCOCORTICOIDS; LIPIDS; NANOPARTICLES; OILS; PARTICLE SIZE; POLYMERS; PROPYLENE GLYCOLS; SOLUBILITY; SPIN LABELS; SURFACE PROPERTIES; TRIGLYCERIDES;

EID: 84994589617     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2016.10.008     Document Type: Article

References (37)

1. [1] Cevc, G., Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev. 56:5 (2004), 675–711.
2. [2] Lucks, J.S., Müller, R.H., König, B., Solid lipid nanoparticles (SLN) – an alternative parenteral drug carrier system. Eur. J. Pharm. Biopharm., 38, 1992, 33S.
3. [3] Siekmann, B., Westesen, K., Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett. 1 (1992), 123–126.
4. [4] Mäder, K., Mehnert, W., Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47:2–3 (2001), 165–196.
5. [5] Müller, R.H., Radtke, M., Wissing, S.A., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54 (2002), 131–155.
6. [6] Müller, R.H., et al. Solid lipid nanoparticles (SLN) – an alternative colloidal carrier system for controlled drug-delivery. Eur. J. Pharm. Biopharm. 41:1 (1995), 62–69.
7. [7] Kuo, Y.C., Chen, H.H., Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int. J. Pharm. 365:1–2 (2009), 206–213.
8. [8] Jores, K., et al. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J. Control. Release 95:2 (2004), 217–227.
9. [9] Saupe, A., Gordon, K.C., Rades, T., Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int. J. Pharm. 314:1 (2006), 56–62.
10. [10] Westesen, K., Bunjes, H., Koch, M.H.J., Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Release 48:2–3 (1997), 223–236.
11. [11] Jores, K., Mehnert, W., Mäder, K., Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharm. Res. 20:8 (2003), 1274–1283.
12. [12] Lombardi Borgia, S., et al. Lipid nanoparticles for skin penetration enhancement – correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Release 110:1 (2005), 151–163.
13. [13] Müller, R.H., Mäder, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur. J. Pharm. Biopharm. 50:1 (2000), 161–177.
14. [14] Pardeike, J., Hommoss, A., Müller, R.H., Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 366:1–2 (2009), 170–184.
15. [15] Andrade, L.M., et al. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Eur. J. Pharm. Biopharm. 88 (2014), 40–47.
16. [16] Schäfer-Korting, M., Mehnert, W., Korting, H.C., Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59 (2007), 427–443.
17. [17] Law, E.H., Leung, M., Corticosteroids in Stevens-Johnson Syndrome/toxic epidermal necrolysis: current evidence and implications for future research. Ann. Pharmacother. 49:3 (2015), 335–342.
18. [18] Marsh, D., Polarity and permeation profiles in lipid membranes. Proc. Natl. Acad. Sci. U.S.A. 98:14 (2001), 7777–7782.
19. [19] Earle, K.A., et al. 250-GHz electron spin resonance studies of polarity gradients along the aliphatic chains in phospholipid membranes. Biophys. J. 66:4 (1994), 1213–1221.
20. [20] Hubbell, W.L., Altenbach, C., Investigation of structure and dynamics in membrane proteins using site-directed spin labeling. Curr. Opin. Struct. Biol. 4 (1994), 566–573.
21. [21] Steinhoff, H.-J., et al. High-field EPR studies of the structure and conformational changes of site-directed spin labeled bacteriorhodopsin. Biochim. Biophys. Acta – Bioenergetics 1457:3 (2000), 253–262.
22. [22] Haag, S.F., et al. Stabilization of reactive nitroxides using invasomes to allow prolonged electron paramagnetic resonance measurements. Skin Pharmacol. Physiol. 24:6 (2011), 312–321.
23. [23] Honzak, L., Sentjurc, M., Swartz, H.M., In vivo EPR of topical delivery of a hydrophilic substance encapsulated in multilamellar liposomes applied to the skin of hairless and normal mice. J. Control. Release 66:2–3 (2000), 221–228.
24. [24] Braem, C., et al. Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. J. Control. Release: Off. J. Control. Release Soc. 119:1 (2007), 128–135.
25. [25] Haag, S.F., et al. Skin penetration enhancement of core-multishell nanotransporters and invasomes measured by electron paramagnetic resonance spectroscopy. Int. J. Pharm. 416:1 (2011), 223–228.
26. [26] Kempe, S., Metz, H., Mäder, K., Application of Electron Paramagnetic Resonance (EPR) spectroscopy and imaging in drug delivery research – chances and challenges. Eur. J. Pharm. Biopharm. 74:1 (2010), 55–66.
27. [27] M.L. Unbehauen, et al., Spin-labelled dexamethasone for Electron-Paramagnetic Resonance (EPR) Spectroscopy, 2016 (in preparation).
28. [28] Weidinger, A., et al. Atomic nitrogen in C60: N@C60. Appl. Phys. A – Mater. Sci. Process. 66 (1998), 287–292.
29. [29] Stoll, S., Schweiger, A., EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J. Magn. Reson. 178:1 (2006), 42–55.
30. [30] Kawamura, T., Matsunami, S., Yonezawa, T., Solvent effects on the g-value of di-t-butyl nitric oxide. Bull. Chem. Soc. Jpn. 40:5 (1967), 1111–1115.
31. [31] Owenius, R., et al. Influence of solvent polarity and hydrogen bonding on the EPR parameters of nitroxide spin label studied by 9-GHz and 95-GHz EPR spectroscopy and DFT calculations. J. Phys. Chem. 105:49 (2001), 10967–10977.
32. [32] Marsh, D., Spin-label EPR for determining polarity and proticity in biomolecular assemblies: transmembrane profiles. Appl. Magn. Reson. 37:1–4 (2010), 435–454.
33. [33] Kim, D.H., Martin, D.C., Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 27:15 (2006), 3031–3037.
34. [34] Saeidpour, S., et al. Localization of dexamethasone within dendritic core-multishell (CMS) nanoparticles and skin penetration properties studied by multifrequency electron paramagnetic resonance (EPR) spectroscopy. Eur. J. Pharm. Biopharm., 2006, 10.1016/j.ejpb.2016.10.001.
35. [35] Freed, J.H., Theory of slow tumbling ESR spectra for nitroxides. Berliner, L.J., (eds.) Spin Labeling Theory and Application, 1976, Academic Press Inc.
36. [36] Sivaramakrishnan, R., et al. Glucocorticoid entrapment into lipid carriers–characterisation by parelectric spectroscopy and influence on dermal uptake. J. Control. Release 97:3 (2004), 493–502.
37. [37] Lukowski, G., Kasbohm, J., Energy dispersive X-ray analysis of loaded solid lipid nanoparticles. J. Proceedings – 28th International Symposium on Controlled Release of Bioactive Materials and 4th Consumer & Diversified Products Conference, San Diego, CA, United Staes, 2001, 516–517.